EW
Edwards Lifesciences Corp
4 super-investors hold EW worth a combined $143M. The largest position: David Rolfe at 2.8% of their portfolio. No cohort buying or selling was filed on the name this quarter. Cohort Conviction Score: 30 — ranked #389 of 724 scored stocks.
Why super-investors own EW
Interest in EW within this cohort remains narrow and largely static: four managers hold a combined $143M, but the position count history — stuck at one or two owners for most of the past eight quarters before a recent uptick to four — signals this is a niche rather than a consensus holding. David Rolfe carries the highest conviction at 2.8% of his portfolio ($14M), while Viking Global Investors holds the largest dollar position ($88M) at a minimal 0.2% weight, suggesting a low-conviction allocation for that fund. Joel Greenblatt holds $42M at a negligible portfolio weight. No one added, trimmed, started, or exited in 2026Q1, indicating a holding pattern with neither enthusiasm nor urgency to exit.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2017Q1 → 2026Q1How many of the cohort members held this stock each quarter.
Owners (4) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Viking Global Investors | 0.2% | 4q | $88M | 1,097,578 |
| 2 | Joel Greenblatt | <0.1% | 39q | $42M | 519,031 |
| 3 | David Rolfe | 2.8% | 37q | $14M | 170,969 |
| 4 | Torray Funds | <0.1% | 7q | $240K | 2,994 |
Owners of EW also hold
Long US equity 13F-HR filings only. CUSIP 28176E108. Not investment advice.